Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Mount Sinai researchers produce cells that resemble hematopoietic stem cells

Mount Sinai researchers produce cells that resemble hematopoietic stem cells

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

BioLineRx starts enrollment in Phase 2 trial of BL-8040 for treatment of AML

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

RPCI, Jasco Pharmaceuticals partner to advance development of cancer therapy

New drug for multiple myeloma could be available within next few months in Europe

New drug for multiple myeloma could be available within next few months in Europe

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

Depressive symptoms linked to early death in cancer survivors

Depressive symptoms linked to early death in cancer survivors

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Entremed reports patent issuance for its lead drug candidate ENMD-2076

Entremed reports patent issuance for its lead drug candidate ENMD-2076

Single antibody could be key to treating multiple myeloma

Single antibody could be key to treating multiple myeloma

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

Senesco completes cohort 2 in Phase 1b/2a clinical study of SNS01-T

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

BioInvent starts BI-505 phase II study in patients with smoldering multiple myeloma

Enrollment for Pharmacyclics' Phase III study using ibrutinib in CLL patients completed

Enrollment for Pharmacyclics' Phase III study using ibrutinib in CLL patients completed

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

New pre-clinical study suggests novel drug combination therapy for leukemia treatment

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

Preclinical data on anti-cancer activity of BI-505 published online in Cancer Cell

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.